[go: up one dir, main page]

MX2015006419A - Tratamiento de la intolerancia al gluten y padecimientos relacionados. - Google Patents

Tratamiento de la intolerancia al gluten y padecimientos relacionados.

Info

Publication number
MX2015006419A
MX2015006419A MX2015006419A MX2015006419A MX2015006419A MX 2015006419 A MX2015006419 A MX 2015006419A MX 2015006419 A MX2015006419 A MX 2015006419A MX 2015006419 A MX2015006419 A MX 2015006419A MX 2015006419 A MX2015006419 A MX 2015006419A
Authority
MX
Mexico
Prior art keywords
intolerance
gluten
treatment
related matters
nepenthesin
Prior art date
Application number
MX2015006419A
Other languages
English (en)
Other versions
MX383754B (es
Inventor
David Schriemer
Martial Rey
Original Assignee
Nepetx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nepetx Llc filed Critical Nepetx Llc
Publication of MX2015006419A publication Critical patent/MX2015006419A/es
Publication of MX383754B publication Critical patent/MX383754B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23012—Nepenthesin (3.4.23.12)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En este documento se proporcionan composiciones, alimentos que comprenden nepentesina o un derivado de la misma, y métodos para utilizar la nepentesina o su derivado para modular la intolerancia al gluten y padecimientos relacionados, tales como la celiaquía.
MX2015006419A 2012-11-21 2013-11-20 Composiciones para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. MX383754B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261729210P 2012-11-21 2012-11-21
US201261797040P 2012-11-27 2012-11-27
PCT/CA2013/000970 WO2014078935A1 (en) 2012-11-21 2013-11-20 Treatment of gluten intolerance and related conditions

Publications (2)

Publication Number Publication Date
MX2015006419A true MX2015006419A (es) 2015-12-15
MX383754B MX383754B (es) 2025-03-14

Family

ID=50728145

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015006419A MX383754B (es) 2012-11-21 2013-11-20 Composiciones para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.
MX2015011825A MX374220B (es) 2012-11-21 2014-03-14 Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2015011825A MX374220B (es) 2012-11-21 2014-03-14 Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.

Country Status (15)

Country Link
US (7) US9005610B2 (es)
EP (1) EP2922568A1 (es)
JP (1) JP6412876B2 (es)
KR (1) KR102296428B1 (es)
CN (1) CN105007934B (es)
AU (1) AU2013350261B2 (es)
CA (1) CA2892474C (es)
DK (1) DK3004340T3 (es)
ES (1) ES2821771T3 (es)
HR (1) HRP20201459T1 (es)
HU (1) HUE050868T2 (es)
IL (2) IL238912B (es)
MX (2) MX383754B (es)
PT (1) PT3004340T (es)
WO (2) WO2014078935A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions
CN105492602B (zh) * 2013-03-15 2021-01-05 科德克希思公司 对麸质不耐受以及相关病症的治疗
WO2015192211A1 (en) 2014-06-16 2015-12-23 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
WO2017106798A2 (en) * 2015-12-16 2017-06-22 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
CA3075590A1 (en) * 2017-09-20 2019-03-28 Aarhus Universitet Nepenthesin-1 derived resistance to fungal pathogens in major crop plants
EP3946394A4 (en) * 2019-04-02 2023-01-11 Sami-Sabinsa Group Limited METHOD AND COMPOSITION FOR THE THERAPEUTIC TREATMENT OF GLUTEN INTOLERANCE
TWI864494B (zh) * 2022-11-17 2024-12-01 國立中興大學 天冬胺酸蛋白酶於水解麩質蛋白之用途、編碼該天冬胺酸蛋白酶之核酸分子、生產該天冬胺酸蛋白酶之方法及其應用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DK81193D0 (da) * 1993-07-06 1993-07-06 Novo Nordisk As Enzym
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JP3521635B2 (ja) 1996-08-07 2004-04-19 日本電信電話株式会社 映像生成方法および映像生成システム
JPH1149697A (ja) * 1997-08-01 1999-02-23 Nisshin Flour Milling Co Ltd ストレス抑制剤及びストレス抑制用食品
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
AU2003215272B2 (en) 2002-02-14 2008-04-03 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
JP4415244B2 (ja) * 2003-02-21 2010-02-17 グリコ栄養食品株式会社 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20060095096A1 (en) 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
US8119385B2 (en) 2005-03-04 2012-02-21 Bp Corporation North America Inc. Nucleic acids and proteins and methods for making and using them
ES2441969T3 (es) * 2005-10-11 2014-02-07 Mofin S.R.L. Productos lácteos con veteado azul "libres de gluten" destinados a personas afectadas por enfermedad celiaca
US8119125B2 (en) 2005-10-11 2012-02-21 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
CA2644273A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
US8148105B2 (en) 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
EP2229404A4 (en) * 2007-12-10 2011-03-09 Univ Leland Stanford Junior ENZYMATIC POLYTHERAPY FOR GASTRIC DIGESTION OF FOOD GLUTEN IN PATIENTS WITH CELIAC DISEASE
ES2616231T3 (es) 2008-08-21 2017-06-12 Immunogenics Llc Formulación para administración oral de proteínas
JP2011049697A (ja) 2009-08-25 2011-03-10 Panasonic Corp フリッカ検出装置、撮像装置、フリッカ検出プログラム、及び、フリッカ検出方法
US9011842B2 (en) 2010-02-02 2015-04-21 Amano Enzyme Inc. Use of proteases for gluten intolerance
WO2011126873A2 (en) 2010-03-30 2011-10-13 Alvine Pharmaceuticals, Inc. Proteases for degrading gluten
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions

Also Published As

Publication number Publication date
CA2892474A1 (en) 2014-05-30
CN105007934A (zh) 2015-10-28
IL238912A0 (en) 2015-07-30
KR102296428B1 (ko) 2021-09-01
US20140140980A1 (en) 2014-05-22
IL283484A (en) 2021-06-30
US10266818B2 (en) 2019-04-23
US20210230569A1 (en) 2021-07-29
HRP20201459T1 (hr) 2020-12-11
DK3004340T3 (da) 2020-09-21
US20170067040A1 (en) 2017-03-09
US20150290301A1 (en) 2015-10-15
CN105007934B (zh) 2019-02-05
US9745565B2 (en) 2017-08-29
HUE050868T2 (hu) 2021-01-28
CA2892474C (en) 2022-06-21
MX374220B (es) 2025-03-05
US20140186330A1 (en) 2014-07-03
PT3004340T (pt) 2020-09-30
US20150265686A1 (en) 2015-09-24
KR20150123783A (ko) 2015-11-04
MX383754B (es) 2025-03-14
US9005610B2 (en) 2015-04-14
WO2014078935A1 (en) 2014-05-30
US11725198B2 (en) 2023-08-15
JP6412876B2 (ja) 2018-10-24
ES2821771T3 (es) 2021-04-27
US9623092B2 (en) 2017-04-18
US10982201B2 (en) 2021-04-20
AU2013350261A1 (en) 2015-07-09
WO2014138927A1 (en) 2014-09-18
EP2922568A1 (en) 2015-09-30
JP2016501853A (ja) 2016-01-21
IL238912B (en) 2021-06-30
MX2015011825A (es) 2016-05-31
AU2013350261B2 (en) 2018-12-06
US20200040322A1 (en) 2020-02-06

Similar Documents

Publication Publication Date Title
PH12019502292A1 (en) Methods and compositions for treatment of a genetic condition
PH12015501720A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
MY172156A (en) Modulators of methyl modifying enzymes, compositions and uses thereof
EA201492219A1 (ru) Соединения и композиции для модуляции egfr активности
CA2865011C (en) Methods and compositions for treating huntington's disease
EA201591451A1 (ru) Модуляторы flap
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UY34472A (es) Derivados modificados de 4-fenil-piridina
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201590534A1 (ru) Новые бициклические производные
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
EA201492223A1 (ru) Новые диазаспироциклоалканы и азаспироциклоалканы
UA110471C2 (ru) 5-алкінілпіримідини
UY34333A (es) ?métodos y composiciones para el control de malezas, y métodos para reducir la expresión de enzima dhps?
EA201490423A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
MX2015006419A (es) Tratamiento de la intolerancia al gluten y padecimientos relacionados.
EA201290642A1 (ru) Соединения и способы
MX359769B (es) Metodos para descelularizar huesos.
UY34314A (es) Derivados de anilina, su preparación y su aplicación terapéutica.
MX2015003701A (es) Composiciones para tratamiento.